which recently have shown to have antitumor activity in multiple myeloma, may also be of therapeutic value in treating primary amyloidosis (Gertz, 2002; Khan & Falk, 2001). A more aggressive ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

Most people with MGUS never get a more serious condition. MGUS can turn into multiple myeloma. It also can turn into another blood disease, either: Amyloidosis Waldenström’s macroglobulinemia ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

Pieter Sonneveld, MD, PhD, chair of the Erasmus MC Cancer Institute, discussed the findings of a study modeling long-term progression-free survival (PFS) in patients with multiple myeloma (MM) treated ...

Dr. Rahul Banerjee is a physician-researcher who specializes in multiple myeloma, a blood cancer caused by plasma cells that can cause bone and kidney damage. Dr. Banerjee also treats patients with AL ...

Dr. Kara Cicero is a hematologist-oncologist focused on global oncology and cancer disparities research to advance health equity, with specific clinical expertise in multiple myeloma, AL amyloidosis ...

It may also occur in association with multiple myeloma (Smith, 2003). Secondary amyloidosis occurs in association with chronic inflammatory or infectious diseases. Most patients who are diagnosed ...